Viking Therapeutics Inc.

NASDAQ: VKTX · Real-Time Price · USD
40.04
-0.20 (-0.50%)
At close: Aug 15, 2025, 3:59 PM
40.02
-0.05%
After-hours: Aug 15, 2025, 04:11 PM EDT

Viking Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-39.9 -20.44 -10.72 -6.58
PEG Ratio
-3.63 -6 -0.42 -0.16
PS Ratio
n/a n/a n/a n/a
PB Ratio
4.98 5.04 4.97 1.76
P/FCF Ratio
-49.98 -23.93 -14.92 -7.46
P/OCF Ratio
-49.98 -23.93 -14.92 -7.46
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.00 0.00 0.01 0.00
Quick Ratio
33.09 19.19 7.61 23.98
Current Ratio
33.09 19.19 7.61 23.98
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a -1.15K n/a -3.09K
Return on Equity
-0.12 -0.25 -0.46 -0.27
Return on Assets
-0.12 -0.23 -0.4 -0.26
Return on Invested Capital
-0.17 -0.29 -0.47 -0.27
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a